scorecardresearch
Add as a preferred source on Google
Saturday, September 27, 2025
TopicBioNTech

Topic: BioNTech

Pfizer Covid vaccine safe for kids aged 5-11 yrs, shows robust antibody response, trail finds

Pfizer and BioNTech SE said phase 1/2/3 trial initially enrolled up to 4,500 kids between 6 months to 11 years in the US, Finland, Poland & Spain from over 90 clinical trial sites.

Beijing delay in approving Pfizer-BioNTech shot raises questions on China’s vaccination plans

Analysts say Beijing's concern might be that approval of the BioNTech shot could be interpreted as an acknowledgment that local shots are less effective than western ones.

8-10 week gap between Pfizer doses boosts antibodies, UK study says

The study said neutralising antibody levels were twice as high after the 10-week interval as with the three-week span.

BioNTech vaccine creates 10 times higher antibody levels compared to Sinovac: Study in Lancet

Researchers noted that antibody concentrations for BioNTech recipients rose 'substantially' after first dose, but Sinovac recipients showed 'low' level of antibodies after first shot.

Could a simple pill beat Covid-19? Pfizer is giving it a go

Where most antiviral agents target the inflammatory and immune response resulting from Covid, Pfizer’s pill directly targets the virus itself.

Pfizer vaccine shows 100% efficacy in 12-15 year olds, is safe for adolescents, US study finds

Study finds Pfizer-BioNTech vaccine has favourable safety profile in 12-15-year-olds, produces greater immune response than in young adults, is highly effective against Covid-19.

Pfizer-BioNTech Covid vaccine cleared for use on adolescents aged 12-15 in US

A group of advisers to Centers for Disease Control and Prevention will meet Wednesday to make recommendations for administering the vaccine. Kids could begin receiving them Thursday.

Discussions on with Indian govt for expedited approval of Pfizer Covid vaccine, says CEO

Pfizer is aware that access to vaccines is critical. Unfortunately, our vaccine is not registered in India although our application was submitted months ago, the CEO added.

Covid-19 pandemic: France lax in containing cases, Palestine wants vaccines from Israel

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

Pfizer-BioNTech vaccine neutralises Brazilian Covid strain in lab experiments

While the research, performed by University of Texas Medical Branch in Galveston, needs to be validated with real-world data, it offers another reason for optimism.

On Camera

Aamir Khan and Salman Khan are still dodging and deflecting the age question, 20 yrs later

On the first episode of Two Much With Kajol and Twinkle, Aamir Khan and Salman Khan were confronted with another hypocrisy: age gaps. And they didn't come out looking good.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

With MiG-21’s exit, India’s squadron strength hits 6-decade low. What are IAF’s plans for the Tejas

While the IAF remains committed to the Tejas programme and has placed orders for 180 Tejas Mk1A, the force is eagerly waiting for the Tejas Mk 2 version.

Something’s hidden in the Oval Office photo of Trump, Munir, Sharif. India must look closely

What Munir has achieved with Trump is a return to normal, ironing out the post-Abbottabad crease. The White House picture gives us insight into how Pakistan survives, occasionally thrives and thinks.